Letzte Communitymeinungen
- 3 User waren zuletzt bullisch
- Im Beta-Tester Jahresendrally Battle 2021
-
Relexy78
14.09.2021
-
Zockrat
29.08.2021
- Im Alpha-Tester Battle 2021
-
Harry386
- Ein User war zuletzt bärisch
- Im Alpha-Tester Short-Battle 2021
-
neuz8user
Ein User hat Bayer abonniert.
Aktionärsstruktur der Bayer
Portrait der Bayer Aktie
Das Unternehmen Bayer aus Deutschland ist in den Bereichen Chemie & Pharma, Pharmazeutika, Spezialchemie, LifeScience, Kunststoffe, Medizinische Produkte / Medizintechnik, Chemie, Biotechnologie, Pharma tätig.
Tochterunternehmen von Bayer sind: Bayer Cropscience Ltd/India, Bayer CropScience Limited.
Bayer ist in mehr als 82 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter First Trust Indxx Global Agriculture ETF gewichtet Bayer mit 9,59% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Bayer Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Bayer am höchsten gewichtet ist Insgesamt in 82 ETFs enthalten
Dir gefallen die Informationen zu Bayer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu Bayer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Bayer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Bayer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
315 News & Informationen zur Bayer Aktie
BAYER AG : Buy rating from Kepler Cheuvreux
Christian Faitz from Kepler Cheuvreux retains his positive opinion on the stock with a Buy rating. The target price remains set at EUR 68. | August 17, 2021
Bayer takes legal battle over Roundup cancer claims to US Supreme Court
Bayer, trying to contain billions of dollars in legal costs, filed a petition with the U.S. Supreme Court to reverse an appeals court verdict that upheld damages to a customer blaming his cancer on the German group's glyphosate-based weedkillers.
Christian Lindner-Portfolio: 3 ETFs sind (k)eine gute Anlageidee?
Was taugt das Christian Lindner-Portfolio mit 3 ETFs aus dem ARD Sommerinterview. Im aktuellen Artikel habe ich es unter die Lupe genommen.
Global Contrast Media Market to Reach $5.2 Billion by 2024
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
The FDA signed off on COVID-19 booster shots for immunocompromised people
These are Insider's biggest healthcare stories for the week ending August 13.
Recursion Pharmaceuticals : Reports Second Quarter 2021 Financials and Provides Business Updates (Form 8-K)
Recursion Reports Second Quarter 2021 Financials and Provides Business Updates
•Expanded the total number of research and development programs from 37 to… | August 13, 2021
Pest Control Market To Touch USD 31.94 Billion at CAGR
Pune, India, Aug. 12, 2021 (GLOBE NEWSWIRE) — The global pest control market size is anticipated to witness substantial growth on account of the…
India Anti-Fungal Drugs Markets Report 2021: Historical Data 2017-2020, Base Year Of 2021, Estimates For 2022 & Forecasts 2023-2027
DUBLIN, Aug. 12, 2021 /PRNewswire/ — The “India Anti-Fungal Drugs Market, By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication,
Verve Therapeutics Announces Business and Program Highlights and Reports Second Quarter 2021 Financial Results
New Preclinical Base Editing Durability Data and Proprietary GalNAc-targeted Lipid Nanoparticle Delivery Technology Data to be Presented at TIDES in…
Regenerative Medicine Market Size Worth $57.08 Billion By 2027: Grand View Research, Inc.
SAN FRANCISCO, Aug. 12, 2021 /PRNewswire/ — The global regenerative medicine market size is expected to reach USD 57.08 billion by 2027, growing …
$86M to California couple upheld in Monsanto pesticide case
Fears Nachawati Law Firm: Chorus Grows for Bayer CEO's Resignation as Juries Return Verdicts in Roundup Cancer Cases
/PRNewswire/ — Cancer victims are calling for Bayer AG CEO Werner Baumann to step down for his failed leadership amid multimillion-dollar jury verdicts…
Belmora Seeks Supreme Court Review In “FLANAX” Trademark Battle With German Big Pharma, Bayer AG
WASHINGTON, Aug. 10, 2021 /PRNewswire/ — Belmora LLC, a small Virginia-based pharmaceutical company, has petitioned the U.S. Supreme Court to review two
Meet biotech's new potential acquirers
These are Insider's biggest healthcare stories for August 10.
Frost & Sullivan Institute Launches Enlightened Growth Leadership Awards Recognizing Top Companies
SANTA CLARA, Calif., Aug. 9, 2021 /CNW/ — Frost & Sullivan Institute Enlightened Growth Leadership Best Practices Recognition honors organization…
BAYER AG : UBS reiterates its Buy rating
UBS analyst Michael Leuchten maintains his Buy rating on the stock. The target price remains set at EUR 85. | August 9, 2021
Drug Delivery Devices Global Markets Report 2021: COVID-19 Impacts, Implications And Growth Factors To 2030
DUBLIN, Aug. 6, 2021 /PRNewswire/ — The “Drug Delivery Devices Global Market Report 2021: COVID-19 Implications and Growth to 2030” report has been added to
BAYER AG : DZ Bank remains its Buy rating
In a research note, DZ Bank analyst Peter Spengler has maintained his recommendation on the stock with a Buy rating. | August 6, 2021
BAYER AG : Deutsche Bank reiterates its Buy rating
In a research note, Deutsche Bank analyst Falko Friedrichs has maintained his recommendation on the stock with a Buy rating. The target price is still set at EUR 66. | August 6, 2021
BAYER AG : Berenberg maintains a Buy rating
In a research note, Berenberg analyst Sebastian Bray has maintained his recommendation on the stock with a Buy rating. The target price is decreased from EUR 74 to EUR 60. | August 6, 2021
BAYER AG : Barclays remains Neutral
Analyst Emily Field from Barclays research gives the stock a Neutral rating. The target price has been revised downwards and is now set at EUR 50 as compared to EUR 55 previously. | August 6, 2021
Bayer Starts Latest Roundup Trial With Leg Up After Three Losses
(Bloomberg) — Bayer AG went to trial Thursday over a California woman’s claims the company’s best-selling Roundup weedkiller caused her cancer in what could be the German conglomerate’s best shot at winning a case after three straight losses averaging almost $50 million in damages for each consumer
Germany stocks higher at close of trade; DAX up 0.33% By Investing.com
Germany stocks higher at close of trade; DAX up 0.33%
Bayer Aktiengesellschaft 2021 Q2 – Results – Earnings Call Presentation (OTCMKTS:BAYZF)
The following slide deck was published by Bayer Aktiengesellschaft in conjunction with their 2021 Q2 earnings call.
Global Cancer Therapies Market to Reach $204.2 Billion by 2024
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
Futures Rise Ahead Of Claims Data; Europe Hits Another Record High
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
BAYER AG : Barclays reiterates its Neutral rating
Barclays's research confirms his advice and maintains his neutral opinion on the stock. The target price is unchanged and still at EUR 55. | August 5, 2021
BAYER AG : Buy rating from Bernstein
Bernstein is positive on the stock with a Buy rating. The target price remains set at EUR 75. | August 5, 2021
BAYER AG : JP Morgan remains its Buy rating
Richard Vosser from JP Morgan retains his positive opinion on the stock with a Buy rating. The target price is still set at EUR 67. | August 5, 2021
Bayer AG reports Q2 results (OTCMKTS:BAYZF)
Bayer AG (BAYZF): Q2 Non-GAAP EPS of €1.59; GAAP EPS of -€9.79.Revenue of €10.85B (+8.0% Y/Y) FY21 Guidance: The company now expect to generate sales of approximately €43…
Bayer 2Q Net Loss Narrowed Despite Litigation Provisions; Raises 2021 Outlook — Update
By Cecilia Butini
Bayer AG said Thursday that its net loss for the second quarter narrowed on year despite provisions for Roundup weedkiller litigation, and raised its outlook for the full… | August 5, 2021
Bayer to buy US start-up Vividion for up to $2bn
German drugs group to snap up biopharmaceuticals group in innovation push
Bayer boosts drug pipeline with Vividion buy, lifts outlook By Reuters
Bayer boosts drug pipeline with Vividion buy, lifts outlook
Bayer Raises 2021 View
By Cecilia Butini Bayer AG said Thursday that its net loss for the second quarter narrowed on year, though it set aside provisions for Roundup weedkiller…
Bayer buys biopharma firm Vividion Therapeutics for up to $2 billion
Breaking News, Latest News and Current News from OANN.com. Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.
Bayer buys biopharma firm Vividion Therapeutics for up to $2 billion By Reuters
Bayer buys biopharma firm Vividion Therapeutics for up to $2 billion
Biotech vs. Pharmaceuticals: What's the Difference?
Biotech and pharma are important industry sectors that differ fundamentally in how they derive medical or healthcare treatments.
Insights on the Targeted Therapeutics Global Market to 2031 – Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others
/PRNewswire/ — The “Targeted Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031” report has been added to…
Insights on the Targeted Therapeutics Global Market to 2031 – Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others
DUBLIN, July 30, 2021 /PRNewswire/ — The 'Targeted Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 202…
The Worldwide Contraceptives Industry is Expected to Reach $29.6 Billion by 2028
/PRNewswire/ — The “Contraceptives Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product, End User, Distribution Channel” report has been…